The meeting is scheduled to be held on Monday, August 10, 2026. The primary agenda items for consideration and approval include:
- The Unaudited Standalone Financial Results of the Company for the quarter ended June 30, 2026 (Q1 FY27)
- The Unaudited Consolidated Financial Results of the Company for the quarter ended June 30, 2026 (Q1 FY27)
- Any other matter with the permission of the Chair
Additionally, in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, and the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the Company's securities has been closed since July 1, 2026. The trading window will remain closed until 48 hours after the declaration of the financial results, specifically until August 12, 2026 (inclusive).